LuisFPorrataMD

Hematology • Rochester, MN

Hematologic Oncology

Assistant Professor, Internal Medicine, Mayo Medical School

Join to view full profile

Dr. Porrata is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Porrata's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1996 - 2000
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1993 - 1996
SUNY Upstate Medical UniversityClass of 1993

Certifications & Licensure

MN State Medical License 1996 - 2025
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma Start of enrollment: 2004 Oct 01
Completed
Phase 1, Phase 2
Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Start of enrollment: 2007 Dec 01
Completed
Phase 3

Publications & Presentations

PubMed

Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy.
Aung M Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J Inwards
Transplantation and Cellular Therapy. 2024-10-01
Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymp...
Luis F Porrata, Stephen M Ansell, Ivana N Micallef, Patrick B Johnston, Jose C Villasboas
Biomedicines. 2024-08-09
2 citations
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.
Aung M Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J Inwards
Haematologica. 2024-07-01

Abstracts/Posters

Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma
Luis Porrata, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019